The Global Allergy Immunotherapy Market is predicted to cross a healthy 10.85% CAGR over the forecast period from 2018 to 2023, with the market rising to a valuation of USD 4,324.7 million, according to the latest research report from Market Research Future (MRFR).
The report presents an in-depth assessment of the Allergy Immunotherapy Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Allergy Immunotherapy Market investments from 2019 till 2023.
The increased predisposition of individuals to allergies is expected to create an advantageous backdrop for the growth of the allergy immunotherapy market. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts.
The increased occurrence of chronic diseases such as asthma, allergy, and diabetes are expected to benefit the allergy immunotherapy market. The market is expected to achieve traction due to the rise in research & development and clinical trials being conducted to test the drugs being formulated. Furthermore, an increased flow of capital in the allergy immunotherapy market is expected to accelerate market growth in the approaching period.
Get Exclusive Sample Copy of “Allergy Immunotherapy Market” Report @ https://www.marketresearchfuture.com/sample_request/1517
Competitive Landscape
Leading players in the global allergy immunotherapy market include
- HAL Allergy Group,
- Merck KGaA (Allergopharma),
- Stallergenes Greer,
- DBV Technologies,
- Circassia,
- Allergy Therapeutics,
- ALK Abello A/S
In August 2019, a new trial was launched by the NIH, Genentech, and Novartis to assess the impact of experimental treatments for various food allergies.
March 19th, 2019, it is revealed that Aimmune’s Biologics License Application is accepted and approved by the US Food and Drug Administration (FDA) for the treatment of curbing down the risk of anaphylaxis in both peanut-allergic adolescents and children.
Segments – Allergy Immunotherapy Market
The global allergy immunotherapy market is segmented on the basis of allergy type and treatment type, in addition to region.
The global allergy immunotherapy market has been segmented on the basis of allergy type into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. Allergic rhinitis holds the largest share in the global allergy immunotherapy market, followed by allergic asthma. The peanut allergy segment is expected to exhibit the highest CAGR, of 11.30%, over the forecast period.
On the basis of treatment, the global allergy immunotherapy market is segmented into subcutaneous immunotherapy (SCIT), sublingual immunotherapy, and specific immunotherapy (SIT). Sublingual immunotherapy is further sub-segmented into sublingual immunotherapy drops and sublingual immunotherapy tablets. Subcutaneous immunotherapy is the leading revenue generator in the global allergy immunotherapy market and is likely to remain in the position over the forecast period due to the high efficacy of subcutaneous immunotherapy. The subcutaneous immunotherapy market is expected to rise to a valuation of USD 2,089.2 million by 2023.
Regional Analysis – Allergy Immunotherapy Market
The global allergy immunotherapy market is expected to be dominated by Europe over the forecast period, with Western Europe emerging as the leading player in the global market and showing all the signs of sustained progress in the coming years. The rising prevalence of allergies in Europe and the growing awareness about the various ways of treating allergies is likely to be the major driver for the allergy immunotherapy market over the forecast period. The widespread prevalence of allergies in Europe has driven research into the epidemiology and treatment of allergies, with several major studies being carried out in the region in order to zero in on the exact nature and cause of various allergies. This is likely to be a major driver for the allergy immunotherapy market in Europe over the forecast period. Almost 150 million were estimated to be suffering from allergies in 2015, a figure expected to reach 50% of all Europeans by 2025; this is likely to drive the allergy immunotherapy market in Europe over the forecast period. The Western Europe market for allergy immunotherapy is expected to rise to USD 954.1 million by 2023.
Americas is also a major regional player in the global allergy immunotherapy market and is likely to remain a key player over the forecast period due to the overall growth of the healthcare research sector, rising prevalence of allergies, and the increasing awareness about various effective ways of treating allergies. The increasing desire to get down to the root cause of allergies and tackle the problem at its origin is likely to be a major driver for the allergy immunotherapy market in North America over the forecast period. The increasing prevalence of food allergies in North America is likely to drive the demand from the allergy immunotherapy market in the Americas over the forecast period. The Americas market for allergy immunotherapy is expected to rise to a valuation of USD 1,409.6 million by 2023.
Asia Pacific is also likely to retain an important place in the global allergy immunotherapy market over the forecast period due to the increasing prevalence of allergies and the increasing desire among the healthcare players in the region to eradicate the problem of allergies effectively. The Asia Pacific market for allergy immunotherapy is expected to exhibit the highest CAGR of 11.32% over the forecast period.
In the Middle East and Africa, the UAE is likely to dominate the market, holding 53.5% of the regional market by the end of the forecast period.
Browse Complete “Allergy Immunotherapy Market” Report @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Your information will never be shared with any third party.